866-997-4948(US-Canada Toll Free)

Global Irritable Bowel Syndrome (IBS) Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 112 Pages

This report studies the global market size of Irritable Bowel Syndrome (IBS) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome (IBS) in these regions.
This research report categorizes the global Irritable Bowel Syndrome (IBS) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is nave and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
In 2017, the global Irritable Bowel Syndrome (IBS) market size was 2640 million US$ and is forecast to 8650 million US in 2025, growing at a CAGR of 16.0% from 2018. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome (IBS) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Irritable Bowel Syndrome (IBS) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Irritable Bowel Syndrome (IBS) include
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

Market Size Split by Type
IBS-D Drug
IBS-C Drug
Other
Market Size Split by Application
Women
Men

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Irritable Bowel Syndrome (IBS) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome (IBS) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Irritable Bowel Syndrome (IBS) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type
1.4.2 IBS-D Drug
1.4.3 IBS-C Drug
1.4.4 Other
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application
1.5.2 Women
1.5.3 Men
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Irritable Bowel Syndrome (IBS) Market Size
2.1.1 Global Irritable Bowel Syndrome (IBS) Revenue 2016-2025
2.1.2 Global Irritable Bowel Syndrome (IBS) Sales 2016-2025
2.2 Irritable Bowel Syndrome (IBS) Growth Rate by Regions
2.2.1 Global Irritable Bowel Syndrome (IBS) Sales by Regions
2.2.2 Global Irritable Bowel Syndrome (IBS) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Irritable Bowel Syndrome (IBS) Sales by Manufacturers
3.1.1 Irritable Bowel Syndrome (IBS) Sales by Manufacturers
3.1.2 Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturers
3.1.3 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.2 Irritable Bowel Syndrome (IBS) Revenue by Manufacturers
3.2.1 Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2018)
3.2.2 Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2016-2018)
3.3 Irritable Bowel Syndrome (IBS) Price by Manufacturers
3.4 Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Product Types
3.4.1 Irritable Bowel Syndrome (IBS) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irritable Bowel Syndrome (IBS) Product Category
3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Sales by Type
4.2 Global Irritable Bowel Syndrome (IBS) Revenue by Type
4.3 Irritable Bowel Syndrome (IBS) Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Irritable Bowel Syndrome (IBS) Breakdown Data by Application

6 North America
6.1 North America Irritable Bowel Syndrome (IBS) by Countries
6.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Countries
6.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Irritable Bowel Syndrome (IBS) by Type
6.3 North America Irritable Bowel Syndrome (IBS) by Application
6.4 North America Irritable Bowel Syndrome (IBS) by Company

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Countries
7.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Irritable Bowel Syndrome (IBS) by Type
7.3 Europe Irritable Bowel Syndrome (IBS) by Application
7.4 Europe Irritable Bowel Syndrome (IBS) by Company

8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Countries
8.1.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Irritable Bowel Syndrome (IBS) by Type
8.3 Asia Pacific Irritable Bowel Syndrome (IBS) by Application
8.4 Asia Pacific Irritable Bowel Syndrome (IBS) by Company

9 Central & South America
9.1 Central & South America Irritable Bowel Syndrome (IBS) by Countries
9.1.1 Central & South America Irritable Bowel Syndrome (IBS) Sales by Countries
9.1.2 Central & South America Irritable Bowel Syndrome (IBS) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Irritable Bowel Syndrome (IBS) by Type
9.3 Central & South America Irritable Bowel Syndrome (IBS) by Application
9.4 Central & South America Irritable Bowel Syndrome (IBS) by Company

10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries
10.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries
10.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Irritable Bowel Syndrome (IBS) by Type
10.3 Middle East and Africa Irritable Bowel Syndrome (IBS) by Application
10.4 Middle East and Africa Irritable Bowel Syndrome (IBS) by Company

11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.1.4 Irritable Bowel Syndrome (IBS) Product Description
11.1.5 Recent Development
11.2 Valeant Pharmaceuticals
11.2.1 Valeant Pharmaceuticals Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.2.4 Irritable Bowel Syndrome (IBS) Product Description
11.2.5 Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.3.4 Irritable Bowel Syndrome (IBS) Product Description
11.3.5 Recent Development
11.4 Sucampo Pharmaceuticals
11.4.1 Sucampo Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.4.4 Irritable Bowel Syndrome (IBS) Product Description
11.4.5 Recent Development
11.5 McNeil Consumer Healthcare
11.5.1 McNeil Consumer Healthcare Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.5.4 Irritable Bowel Syndrome (IBS) Product Description
11.5.5 Recent Development
11.6 Sebela Pharmaceuticals
11.6.1 Sebela Pharmaceuticals Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.6.4 Irritable Bowel Syndrome (IBS) Product Description
11.6.5 Recent Development
11.7 Astellas Pharmaceuticals
11.7.1 Astellas Pharmaceuticals Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.7.4 Irritable Bowel Syndrome (IBS) Product Description
11.7.5 Recent Development
11.8 IM HealthScience
11.8.1 IM HealthScience Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome (IBS)
11.8.4 Irritable Bowel Syndrome (IBS) Product Description
11.8.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Irritable Bowel Syndrome (IBS) Raw Material
13.1.2 Irritable Bowel Syndrome (IBS) Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Irritable Bowel Syndrome (IBS)
Figure Global Irritable Bowel Syndrome (IBS) Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Irritable Bowel Syndrome (IBS) Production Market Share by Types (Product Category) in 2017
Figure IBS-D Drug Product Picture
Table Major Manufacturers of IBS-D Drug
Figure IBS-C Drug Product Picture
Table Major Manufacturers of IBS-C Drug
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Women
Figure Men
Figure Irritable Bowel Syndrome (IBS) Report Years Considered
Figure Global Irritable Bowel Syndrome (IBS) Market Size 2016-2025 (Million US$)
Figure Global Irritable Bowel Syndrome (IBS) Sales 2016-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Sales by Regions 2016-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions 2016-2025
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions 2016-2025
Figure 2017 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Revenue by Regions 2016-2025 (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions 2016-2025
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions 2016-2025
Figure 2017 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2018) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers in 2017
Table Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2018) (Million US$)
Table Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2016-2018)
Figure Irritable Bowel Syndrome (IBS) Value Share by Manufacturers in 2017
Table Global Irritable Bowel Syndrome (IBS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Irritable Bowel Syndrome (IBS) Price (2016-2018) (USD/Unit)
Table Irritable Bowel Syndrome (IBS) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Irritable Bowel Syndrome (IBS) Product Category
Table Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2025) (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type in 2017
Table Irritable Bowel Syndrome (IBS) Price by Type 2013-2018 (USD/Unit)
Table Global Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2016-2025)
Figure Global Sales Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2025)
Figure Global Sales Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2025)
Figure North America Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2025 (K Units)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2025 (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Sales by Countries (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries
Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2016-2025) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries
Figure United States Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Market Share by Type
Table North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Market Share by Application
Table North America Irritable Bowel Syndrome (IBS) Sales by Company (2016-2018) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2018)
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Figure Europe Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2025 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2016-2025) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries
Figure Germany Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (K Units)
Figure France Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure France Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Market Share by Type
Table Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Market Share by Application
Table Europe Irritable Bowel Syndrome (IBS) Sales by Company (2016-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries
Table Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries
Figure China Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure China Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure India Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure India Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Market Share by Type
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Market Share by Application
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Company (2016-2018) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2018)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Figure Central & South America Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Countries (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries
Table Central & South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries
Figure Brazil Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Market Share by Type
Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Market Share by Application
Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Company (2016-2018) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2018)
Figure Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries
Figure GCC Countries Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Share by Type
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Share by Application
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Table Allergan Company Details
Table Allergan Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Allergan Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Valeant Pharmaceuticals Recent Development
Table Takeda Company Details
Table Takeda Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Takeda Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sucampo Pharmaceuticals Recent Development
Table McNeil Consumer Healthcare Company Details
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table McNeil Consumer Healthcare Recent Development
Table Sebela Pharmaceuticals Company Details
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sebela Pharmaceuticals Recent Development
Table Astellas Pharmaceuticals Company Details
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astellas Pharmaceuticals Recent Development
Table IM HealthScience Company Details
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table IM HealthScience Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Irritable Bowel Syndrome (IBS) Value Chain
Table Typical Suppliers of Key Irritable Bowel Syndrome (IBS) Raw Material
Table Irritable Bowel Syndrome (IBS) Customers List
Table Irritable Bowel Syndrome (IBS) Sales Channels
Table Irritable Bowel Syndrome (IBS) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *